体外诊断契约製造市场－全球产业规模、份额、趋势、机会及预测（依设备类型、技术、服务类型、地区及竞争格局划分，2021-2031年）

全球体外诊断设备契约製造市场预计将从 2025 年的 195.2 亿美元成长到 2031 年的 379.3 亿美元，复合年增长率达到 11.71%。

该市场将体外诊断试剂、试剂和仪器的生产外包给专业的第三方机构，从而确保符合监管要求并提高营运效率。推动这一增长的关键因素是慢性病和感染疾病在全球范围内的日益流行，这反过来又需要扩充性的检测解决方案和大规模生产能力。此外，不断增加的成本压力也促使原始设备製造商 (OEM) 与外部供应商合作，这使他们能够在降低供应链风险的同时，减少设备方面的资本支出。

然而，市场扩张的一大障碍是国际法规结构的日益收紧，这造成了合规瓶颈和财务压力。向这些更严格的标准过渡需要大量的临床证据和文件，这将显着影响生产週期。据欧洲医疗技术协会（MedTech Europe）称，到2024年，根据新的体外诊断医疗设备法规（IVDR），认证和维修成本可能比先前的指令增加高达100%。监管成本的大幅成长迫使製造商转移关键资源，扼杀了创新，并可能延迟重要诊断产品的上市。

市场驱动因素

慢性病和感染疾病的日益普及是推动全球体外诊断（IVD）契约製造市场成长的主要因素，也因此对诊断产品的扩充性提出了前所未有的高要求。非传染性疾病和病毒感染疾病的日益严重迫使原始设备製造商（OEM）利用契约製造组织来应对检测量的激增，同时避免自身产能过度扩张。疾病发生率的上升也凸显了这一需求；例如，美国癌症协会于2024年1月发布的《2024年癌症事实与数据》报告预测，美国新增癌症病例数将首次超过200万例。日益增长的疾病负担要求提高诊断试剂和试剂的生产效率，这也强化了第三方生产商在确保市场供应连续性方面发挥的关键作用。

同时，随着原始设备製造商 (OEM) 将策略重点转向核心竞争力及研发优化，并透过外包生产来寻求成本效益，他们正在重塑产业格局。製造商日益将创新与生产分离，并将资金投入高附加价值环节，而非固定生产资产。例如，罗氏公司于 2024 年 2 月发布的 2023 年年度报告显示，其诊断部门将专门投入 17 亿瑞士法郎用于研发，以加速产品组合的扩张。这些对智慧财产权的巨额投资，使得企业必须将营运执行外包给外部合作伙伴，以维持资产负债表的柔软性。希森美康宣布将于 2024 年投资 30 亿日圆在印度新建一家试剂生产工厂，也印证了这个趋势。

市场挑战

日益严格的国际法规结构正对全球体外诊断（IVD）契约製造市场的成长构成重大障碍。随着监管机构实施更严格的标准，契约製造製造商被迫投入巨资升级品管系统并扩展文件能力，以确保合规性。这项要求分散了原本用于扩大生产规模和技术创新的资金和人力资源，直接影响了营运效率。因此，新诊断产品的上市流程被延长，导致从研发到大规模生产的进程显着延迟，并限制了製造商应对紧急医疗需求的灵活性。

这些监管瓶颈导致等候核准时间延长、产能利用不足以及持续的不确定性，实际上冻结了潜在的收入来源。据欧洲医疗技术协会（MedTech Europe）称，截至2024年，体外诊断试剂生产商完成品管系统认证或技术文件评估的平均时间约为18个月。这一漫长的过程限制了契约製造製造商快速完成大订单的能力，减缓了市场发展势头，并降低了外包对优先考虑快速将诊断解决方案推向市场的原始设备製造商（OEM）的吸引力。

市场趋势

智慧工厂自动化和工业4.0技术的应用正在革新生产线，透过整合机器人技术和即时数据分析，提高生产精度并最大限度地减少人为错误。契约製造製造商正积极部署互联繫统，监控复杂诊断试剂盒生产过程中的关键品质属性，确保在不影响产量的前提下，符合严格的放行标准。这项技术革新超越了传统的机械化，其驱动力在于对微量试剂和复杂组装步骤进行绝对可重复性处理的需求。根据生物梅里埃公司于2025年3月发布的2024年财务报告，该公司报告的资本支出为3.46亿欧元，其中大部分专门用于扩大和自动化其在美国的生产能力，以支持其业务发展。

此外，随着企业将供应链韧性置于仅依赖低成本劳动力模式之上，近岸外包和区域製造策略的日益普及正在从根本上改变市场格局。为了降低跨境物流风险和地缘政治不稳定因素，原始设备製造商（OEM）正在建立更靠近终端用户的区域生产中心，从而显着缩短前置作业时间并降低库存脆弱性。与集中式全球模式相比，这种策略性分散化使企业能够更快地应对区域性健康危机和不断变化的当地监管要求。作为这一趋势的显着例证，赛默飞世尔科技公司在2025年4月的新闻稿中宣布，将在未来四年内向美国追加投资20亿美元，以加强国内製造业务并支持具有韧性的区域医疗供应链。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球体外诊断契约製造市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依设备分类（体外诊断设备、体外诊断耗材）
  • 依技术分类（免疫检测、临床化学、分子诊断、微生物学、血液学、凝血和止血等）
  • 依服务类型（製造服务、检测开发服务、其他服务）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美体外诊断契约製造市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲体外诊断契约製造市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区体外诊断契约製造市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲体外诊断契约製造市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美洲体外诊断契约製造市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球体外诊断契约製造市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Ortho Clinical Diagnostics
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Quidel Corporation
• BioMerieux SA

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global IVD Contract Manufacturing Market is projected to expand from USD 19.52 Billion in 2025 to USD 37.93 Billion by 2031, achieving a compound annual growth rate of 11.71%. This market involves outsourcing the production of in vitro diagnostic tests, reagents, and instruments to specialized third-party entities, ensuring both regulatory compliance and operational efficiency. Key drivers fueling this growth include the increasing global prevalence of chronic and infectious diseases, which demands scalable testing solutions and high-volume production capabilities. Furthermore, original equipment manufacturers are increasingly driven by cost pressures to partner with external providers, allowing them to reduce capital expenditures on facilities while mitigating supply chain risks.

However, a major obstacle hindering market expansion is the growing stringency of international regulatory frameworks, which creates compliance bottlenecks and financial pressure. Transitioning to these rigorous standards requires extensive clinical evidence and documentation, disproportionately impacting manufacturing timelines. According to MedTech Europe, in 2024, certification and maintenance costs under the new In Vitro Diagnostic Regulation rose by up to 100% compared to previous directives. This significant increase in regulatory expenses forces manufacturers to divert essential resources, potentially stifling innovation and delaying the introduction of critical diagnostic products to the market.

Market Driver

The escalating prevalence of chronic and infectious diseases acts as a primary engine for growth in the Global IVD Contract Manufacturing Market, creating a critical need for unprecedented scalability in diagnostic production. As the burden of non-communicable diseases and viral outbreaks grows, original equipment manufacturers are compelled to utilize contract manufacturing organizations to handle surging testing volumes without overextending their internal capacities. This demand is underscored by rising disease incidence; for instance, the American Cancer Society's 'Cancer Facts & Figures 2024' report from January 2024 projects that new cancer cases in the United States will exceed 2 million for the first time. Such elevated disease burdens necessitate higher manufacturing throughput for diagnostic assays and reagents, reinforcing the vital role of third-party producers in ensuring continuous market supply.

Simultaneously, a strategic shift among OEMs toward optimizing core competencies and research and development is reshaping the sector, as companies seek cost efficiencies through outsourced fabrication. Manufacturers are increasingly separating innovation from production, allocating financial resources toward high-value discovery phases rather than fixed manufacturing assets. For example, Roche's 'Annual Report 2023', released in February 2024, indicates that its Diagnostics Division allocated CHF 1.7 billion specifically to research and development to accelerate portfolio expansion. This heavy investment in intellectual property necessitates the use of external partners for operational execution to maintain balance sheet flexibility, a trend further reflected in Sysmex Corporation's 2024 announcement of a 3 billion JPY investment to establish a new reagent manufacturing facility in India.

Market Challenge

The increasing strictness of international regulatory frameworks poses a formidable barrier to the growth of the Global IVD Contract Manufacturing Market. As regulatory bodies enforce more rigorous standards, contract manufacturing organizations must invest heavily in upgraded quality management systems and extensive documentation capabilities to remain compliant. This necessity diverts capital and personnel focus away from production scalability and technological upgrades, directly impacting operational efficiency. Consequently, the onboarding process for new diagnostic products becomes prolonged, causing significant delays in the transition from development to mass production and limiting manufacturers' agility in responding to urgent health demands.

These regulatory bottlenecks result in extended periods of uncertainty where manufacturing capacity remains underutilized while awaiting approvals, effectively freezing potential revenue streams. According to MedTech Europe, in 2024, the average time required for in vitro diagnostic manufacturers to complete Quality Management System or Technical Documentation Assessment certification was approximately 18 months. This prolonged duration restricts the ability of contract manufacturers to execute high-volume orders promptly, thereby stalling market momentum and reducing the appeal of outsourcing for original equipment manufacturers who rely on rapid speed-to-market for their diagnostic solutions.

Market Trends

The implementation of Smart Factory Automation and Industry 4.0 Technologies is revolutionizing production lines by integrating robotics and real-time data analytics to enhance precision and minimize human error. Contract manufacturing organizations are increasingly deploying interconnected systems that monitor critical quality attributes during the fabrication of complex diagnostic kits, ensuring strict adherence to release criteria without compromising throughput speed. This technological evolution is driven by the necessity to handle micro-volume reagents and intricate assembly processes with absolute reproducibility, surpassing traditional mechanization. According to bioMerieux's '2024 Financial Results' from March 2025, the company reported capital expenditures of €346 million, with a significant portion allocated specifically to the expansion and automation of its manufacturing capacities in the United States to support operational advancement.

Additionally, the increasing adoption of nearshoring and localized manufacturing strategies is fundamentally altering the geographic footprint of the market as companies prioritize supply chain resilience over models based solely on low-cost labor. To mitigate risks associated with cross-border logistics and geopolitical instability, original equipment manufacturers are establishing regional production hubs closer to end-users, thereby drastically reducing lead times and inventory vulnerabilities. This strategic decentralization allows firms to respond more swiftly to regional health crises and changing local regulatory requirements compared to centralized global models. Highlighting this trend, Thermo Fisher Scientific committed an additional $2 billion investment in the United States over four years in an April 2025 press release, aiming to enhance domestic manufacturing operations and support a resilient local healthcare supply chain.

Key Market Players

• Thermo Fisher Scientific Inc.
• Siemens Healthineers AG
• Danaher Corporation
• F. Hoffmann-La Roche Ltd.
• Ortho Clinical Diagnostics
• Abbott Laboratories
• Bio-Rad Laboratories, Inc.
• Sysmex Corporation
• Quidel Corporation
• BioMerieux SA

Report Scope

In this report, the Global IVD Contract Manufacturing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

IVD Contract Manufacturing Market, By Device Type

• IVD Equipment
• IVD Consumables

IVD Contract Manufacturing Market, By Technology

• Immunoassay
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Hematology
• Coagulation & Hemostasis
• Others

IVD Contract Manufacturing Market, By Service Type

• Manufacturing Services
• Assay Development Services
• Other Services

IVD Contract Manufacturing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global IVD Contract Manufacturing Market.

Available Customizations:

Global IVD Contract Manufacturing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global IVD Contract Manufacturing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Device Type (IVD Equipment, IVD Consumables)
  • 5.2.2. By Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology, Hematology, Coagulation & Hemostasis, Others)
  • 5.2.3. By Service Type (Manufacturing Services, Assay Development Services, Other Services)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America IVD Contract Manufacturing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Device Type
  • 6.2.2. By Technology
  • 6.2.3. By Service Type
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States IVD Contract Manufacturing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Device Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Service Type
  • 6.3.2. Canada IVD Contract Manufacturing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Device Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Service Type
  • 6.3.3. Mexico IVD Contract Manufacturing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Device Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Service Type

7. Europe IVD Contract Manufacturing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Device Type
  • 7.2.2. By Technology
  • 7.2.3. By Service Type
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany IVD Contract Manufacturing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Device Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Service Type
  • 7.3.2. France IVD Contract Manufacturing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Device Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Service Type
  • 7.3.3. United Kingdom IVD Contract Manufacturing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Device Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Service Type
  • 7.3.4. Italy IVD Contract Manufacturing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Device Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Service Type
  • 7.3.5. Spain IVD Contract Manufacturing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Device Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Service Type

8. Asia Pacific IVD Contract Manufacturing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Device Type
  • 8.2.2. By Technology
  • 8.2.3. By Service Type
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China IVD Contract Manufacturing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Device Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Service Type
  • 8.3.2. India IVD Contract Manufacturing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Device Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Service Type
  • 8.3.3. Japan IVD Contract Manufacturing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Device Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Service Type
  • 8.3.4. South Korea IVD Contract Manufacturing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Device Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Service Type
  • 8.3.5. Australia IVD Contract Manufacturing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Device Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Service Type

9. Middle East & Africa IVD Contract Manufacturing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Device Type
  • 9.2.2. By Technology
  • 9.2.3. By Service Type
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia IVD Contract Manufacturing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Device Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Service Type
  • 9.3.2. UAE IVD Contract Manufacturing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Device Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Service Type
  • 9.3.3. South Africa IVD Contract Manufacturing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Device Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Service Type

10. South America IVD Contract Manufacturing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Device Type
  • 10.2.2. By Technology
  • 10.2.3. By Service Type
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil IVD Contract Manufacturing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Device Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Service Type
  • 10.3.2. Colombia IVD Contract Manufacturing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Device Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Service Type
  • 10.3.3. Argentina IVD Contract Manufacturing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Device Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Service Type

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global IVD Contract Manufacturing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Thermo Fisher Scientific Inc.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Siemens Healthineers AG
• 15.3. Danaher Corporation
• 15.4. F. Hoffmann-La Roche Ltd.
• 15.5. Ortho Clinical Diagnostics
• 15.6. Abbott Laboratories
• 15.7. Bio-Rad Laboratories, Inc.
• 15.8. Sysmex Corporation
• 15.9. Quidel Corporation
• 15.10. BioMerieux SA

16. Strategic Recommendations

17. About Us & Disclaimer